Charlotte's Web Holdings, Inc. (6CW.F)

0.0640

+0.0040

+(6.67%)

As of 3:44:28 PM GMT+2. Market Open.

Charlotte's Web Holdings Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.16 loss in FY 2023)

Charlotte's Web Holdings ( TSE:CWEB ) Full Year 2024 Results Key Financial Results Revenue: US$49.7m (down 21% from FY...

Simply Wall St. last month

CWBHF
Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results

(TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year-ended December 31, 2024.

CNW Group last month

CWBHF
Charlotte's Web 2024 Fourth Quarter Earnings Call and Webcast Notice

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") the market leader in cannabidiol (CBD) hemp extract wellness products, will report its 2024 fourth quarter and year-end results prior to market open on March 19, 2025. A conference call to review the results is scheduled for the same day at 11:00 A.M. Eastern Time.

CNW Group 2 months ago

CWBHF
Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a market leader in hemp extract wellness products, is pleased to announce that the U.S. Food and Drug Administration (FDA) has completed its review of Phase 1 data and Investigational New Drug (IND) application submitted by DeFloria, Inc. ("DeFloria"). The FDA has concluded that DeFloria may now proceed with its planned FDA Phase 2 clinical trial for its botanical pharmaceutical candidate, AJA001 Oral

CNW Group 2 months ago

CWBHF
DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)

DeFloria, Inc., a collaboration between Ajna BioSciences PBC and Charlotte's Web Holdings, Inc. (TSX: CWEB, OTCQX: CWBHF), announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for AJA001, an orally delivered, multi-cannabinoid botanical drug, concluding that the Company may proceed with its planned Phase 2 clinical trial. DeFloria is developing AJA001 as a treatment for symptoms of autism spectrum disorder (ASD) and

PR Newswire 2 months ago

CWBHF
Charlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") the market leader in cannabidiol (CBD) hemp extract wellness products, is pleased to share an update on the progress of DeFloria LLC's ("DeFloria") botanical pharmaceutical development, an entity established by AJNA BioSciences and Charlotte's Web. Promising findings from DeFloria's Phase 1 clinical trial results for AJA001 were presented by Dr. Marcel Bonn-Miller at the American College of Neuropsycho

PR Newswire 4 months ago

CWBHF
DeFloria Announces Positive Results from Phase 1 Trial of AJA001 Being Developed for the Treatment of Autism Spectrum Disorder (ASD)

DeFloria, a joint venture between Ajna BioSciences and Charlotte's Web (TSX: CWEB, OTCQX: CWBHF), reported positive results from a Phase 1 single ascending and multiple ascending dose trial of AJA001 in development for the treatment of symptoms of autism spectrum disorder (ASD) in a poster presentation at the 63rd Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona. AJA001 is an orally delivered, multi-cannabinoid botanical drug product (BDP) designed to provide

PR Newswire 4 months ago

CWBHF
Charlotte's Web Reports 2024 Third quarter Financial Results

(TSX: CWEB, OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a market leader in hemp-derived CBD and other botanical wellness products, today reported financial results for the third quarter ended September 30, 2024.

CNW Group 5 months ago

CWBHF
TSX Penny Stocks To Watch In October 2024

In the last week, the Canadian market has stayed flat, but it is up 27% over the past year, with earnings forecast to grow by 16% annually. For those looking to invest in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value. This article highlights three penny stocks that demonstrate financial strength and could potentially provide long-term opportunities for investors willing to explore beyond established names.

Simply Wall St. 6 months ago

CYDVF

CWBHF

SUNPF
Tilray Brands Launches Charlotte’s Web™ CBD Gummies in Canada

TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, announced the launch of new Charlotte's Web (TSX: CWEB) (OTCQX: CWBHF) CBD gummies in Canada. Designed specifically for daily CBD consumers, Charlotte’s Web CBD Rest Gummies and CBD Life Gummies offer an easy, delicious, and convenient way to incorporate CBD into your wellness routine. The new gummies are available in a 30-pack bottle with t

GlobeNewswire 7 months ago

CWBHF

TLRY
ONE HEMP Hails Long Overdue Congressional Action Toward the Regulation of CBD as a Dietary Supplement

Today ONE HEMP – a coalition of industry leaders committed to advancing regulatory standards for hemp-derived cannabinoid (CBD) products – hailed long overdue Congressional action toward the regulation of CBD as a dietary supplement with the introduction of the Cannabinoid Safety and Regulation Act (CSRA) by Senator Ron Wyden (OR). This legislative milestone builds upon the collaborative work between industry leaders, including Charlotte's Web (TSX: CWEB) (OTCQX: CWBHF), which has been at the fo

CNW Group 7 months ago

CWBHF
Charlotte's Web Responds to New Regulatory Developments in California Affecting the Sale of Hemp CBD Products

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in cannabidiol (CBD) hemp extract wellness products, stands in firm opposition to the new regulations in California that restrict the sale of many ingestible full-spectrum hemp CBD products that meet federal requirements. As a leader in the hemp industry, the Company will continue working directly with the Governor and state legislators to push for changes or new legislation to prese

PR Newswire 7 months ago

CWBHF
Earnings Release: Here's Why Analysts Cut Their Charlotte's Web Holdings, Inc. (TSE:CWEB) Price Target To CA$0.65

Charlotte's Web Holdings, Inc. ( TSE:CWEB ) just released its latest quarterly report and things are not looking great...

Simply Wall St. 8 months ago

CWBHF
Charlotte's Web Holdings Second Quarter 2024 Earnings: Misses Expectations

Charlotte's Web Holdings ( TSE:CWEB ) Second Quarter 2024 Results Key Financial Results Revenue: US$12.3m (down 23...

Simply Wall St. 8 months ago

CWBHF
Charlotte's Web Reports 2024 Second Quarter Financial Results

(TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2024.

PR Newswire 8 months ago

CWBHF
Charlotte's Web 2024 Second Quarter Earnings Call and Webcast Notice

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") the market leader in cannabidiol (CBD) hemp extract wellness products, will report its 2024 second quarter results prior to market open on August 8, 2024. A conference call to review the results is scheduled for the same day at 11:00 A.M. Eastern Time.

PR Newswire 9 months ago

CWBHF
Charlotte's Web Debuts at Walmart with New CBD Topical Collection

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the leader in hemp-derived CBD wellness products, is pleased to announce that its products are now available at Walmart. Starting this month, consumers will find Charlotte's Web CBD topical products in 827 Walmart stores across five states including California, Illinois, Florida, Texas, and Pennsylvania.

CNW Group 10 months ago

CWBHF
Charlotte's Web Appoints Erika Lind as Chief Financial Officer

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the leading provider of hemp-derived CBD wellness products, is pleased to announce the appointment of Erika Lind as Chief Financial Officer (CFO), replacing Jessica Saxton who has resigned from the Company to pursue other interests effective June 28th, 2024. Ms. Lind's appointment is effective June 29, 2024.

PR Newswire 10 months ago

CWBHF
Charlotte's Web Announces Shareholder Meeting Voting Results

(TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the results from its 2024 annual general and special meeting of shareholders held on June 13, 2024, via live audio webcast (the "Meeting"). Each of the matters voted upon at the Meeting is discussed in detail in the Company's Proxy Statement dated April 29, 2024, a copy of which is available on the Company's SEDAR profile at www.sedarplus.ca and on EDGAR at www.sec.gov.

CNW Group 10 months ago

CWBHF

Performance Overview

Return	6CW.F	S&P/TSX Composite index (^GSPTSE)
YTD	+5.79%	+3.70%
1-Year	-53.28%	+14.45%
3-Year	-89.17%	+29.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

TARIFFS LATEST

Charlotte's Web Holdings, Inc. (6CW.F)

Charlotte's Web Holdings Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.16 loss in FY 2023)

Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results

Charlotte's Web 2024 Fourth Quarter Earnings Call and Webcast Notice

Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment

DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)

Charlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder

DeFloria Announces Positive Results from Phase 1 Trial of AJA001 Being Developed for the Treatment of Autism Spectrum Disorder (ASD)

Charlotte's Web Reports 2024 Third quarter Financial Results

TSX Penny Stocks To Watch In October 2024

Tilray Brands Launches Charlotte’s Web™ CBD Gummies in Canada

ONE HEMP Hails Long Overdue Congressional Action Toward the Regulation of CBD as a Dietary Supplement

Charlotte's Web Responds to New Regulatory Developments in California Affecting the Sale of Hemp CBD Products

Earnings Release: Here's Why Analysts Cut Their Charlotte's Web Holdings, Inc. (TSE:CWEB) Price Target To CA$0.65

Charlotte's Web Holdings Second Quarter 2024 Earnings: Misses Expectations

Charlotte's Web Reports 2024 Second Quarter Financial Results

Charlotte's Web 2024 Second Quarter Earnings Call and Webcast Notice

Charlotte's Web Debuts at Walmart with New CBD Topical Collection

Charlotte's Web Appoints Erika Lind as Chief Financial Officer

Charlotte's Web Announces Shareholder Meeting Voting Results

Performance Overview